tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Daina Graybosch, 89 are a BUY (82.41%), 19 are a HOLD (17.59%).
Analyst Daina Graybosch, currently employed at LEERINK, carries an average stock price target met ratio of 26.4% that have a potential upside of 35% achieved within 182 days.
Daina Graybosch’s has documented 187 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TSVT, 2Seventy Bio at 31-Jan-2024.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for SBTX (SILVERBACK THERAPEUTICS ) at 12/29/2020. The price target of $40 was fulfilled within 1 day with a profit of $3 (8.11%) receiving and performance score of 81.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$96
$9.83 (11.41%)
$96
8 days ago
(31-Oct-2024)
15/17 (88.24%)
$11.73 (13.92%)
99
Buy
$122
$35.83 (41.58%)
$83
21 days ago
(18-Oct-2024)
3/4 (75%)
$25.14 (25.95%)
88
Buy
$115
$28.83 (33.46%)
$85
22 days ago
(17-Oct-2024)
7/8 (87.5%)
$19.73 (20.71%)
128
Buy
$87
$0.83 (0.96%)
$57
4 months 21 days ago
(18-Jun-2024)
3/3 (100%)
$33.19 (61.68%)
181
Buy
$80
$-6.17 (-7.16%)
$82
5 months 26 days ago
(13-May-2024)
8/8 (100%)
$30.23 (60.74%)
117
What Year was the first public recommendation made by Daina Graybosch?
